Cholinergic nucleus degeneration and its association with gait impairment in Parkinson's disease.
Xiaodan Zhang, Mateng Wang, Shi Yeow Lee and 7 others
PMID 39026279WHAT IT FOUND
In Parkinson's patients, degeneration in the right cholinergic brain regions was linked to slower walking, shorter strides, and reduced ankle movement.
This association persisted even when controlling for cognitive scores or medication dose, suggesting a direct link between this specific brain atrophy and gait impairment.
Key findings
01After correcting for multiple comparisons, only the right cholinergic basal forebrain showed significant associations with stride length, gait velocity, stance phase, toe-off, and heel-strike angles during both single-task and dual-task walking.
02Adding clinical scores for motor severity, cognition, mood, or levodopa dose to the statistical models did not change the observed associations between gait parameters and cholinergic nucleus degeneration.
03Patients with early-stage Parkinson's disease (Hoehn and Yahr stages 1-2) showed no significant brain atrophy in these cholinergic regions compared to controls, yet still exhibited strong correlations between right-sided degeneration and gait performance.
STILL TO COME
How it was doneWhat they foundWhat it means for PTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was cross-sectional, so it cannot prove that cholinergic degeneration causes gait impairment, only that they are associated. All patients were tested in the 'off' medication state, which means both dopaminergic and cholinergic deficiencies were present, making it difficult to isolate the specific contribution of cholinergic loss. The study did not find correlations between gait parameters and brain structure in the healthy control group, which limits the ability to establish a direct pathophysiological link specific to the disease process. Subgroup analyses were limited by sample size, focusing only on specific groups like non-FOG patients or those with left-onset symptoms. The cognitive assessments used may have been less sensitive due to the low education level of the participant group, potentially masking cognitive contributions to gait.
Declared interests
Funding was provided by the Basic Public Welfare Research Program of Zhejiang Province, the Medical Scientific Research Foundation of Zhejiang Province, the NINGBO Leading Medical&Health Discipline, and the HwaMei Research Foundation of Ningbo No.2 Hospital. No other conflicts of interest were declared.
The easy way to misread this
Do not interpret the lack of significant atrophy in early-stage patients as evidence that their gait problems are not brain-based. The study found strong links between right-sided cholinergic structure and gait performance in early-stage patients even before significant volume loss was detectable compared to controls.